PSMD14 and lung adenocarcinoma: Subsequent investigations should prioritize the clinical implications of PSMD14 and its viability as a therapeutic target within the realm of immunotherapy, to provide enhanced treatment modalities for patients diagnosed with lung adenocarcinoma.